Written and maintained by CASRAI Editorial Board
Last updated
Short answer
Dendritic cell function is the capture of antigen and the use of it to start and steer T cell responses. Dendritic cells (DCs) take up material at sites of infection or injury, mature in response to danger signals such as Toll-like receptor (TLR) ligation, migrate toward lymphatic vessels, and present antigen to T cells. Different DC subsets do different jobs, and what you measure in a lab depends heavily on the DC model used.
Definition and scope
DCs are not a single cell type. A 2020 review describes them as “a heterogenic population of cells that comprise several lineages”: conventional DC type 1 (cDC1), conventional DC type 2 (cDC2), plasmacytoid DCs (pDCs), Langerhans cells and inflammatory monocyte-derived DCs (moDCs). cDC1 and cDC2 have largely non-redundant functions in priming and regulating T cell responses. This page covers the functions of dendritic cells (the question is also asked as “dendritic cell functions”, “dendritic cells function” and “function of dendritic cells”) at the level a lab or clinic team needs when reading immunology papers or planning DC assays. It is general information, not individual medical advice, and it describes no procedures.
For the wider field, see the CASRAI overview What Is Immunology?, and for the cell-level background What Is Cell Biology?.
How dendritic cells work: capture, maturation, migration, presentation
Capture and activation
Antigen is captured by migratory cDC1s or CD11b+ cDCs (cDC2s) at the site of infection. Immature, quiescent DCs rely on fatty acid oxidation; on activation their metabolism shifts to glycolysis.
Migration
After TLR ligation, DCs upregulate the chemokine receptor CCR7 and are drawn toward lymphatic vessels, which secrete the CCR7 ligand CCL21.
Presentation and cross-presentation
Presenting internalized antigen on MHC class I molecules is called cross-presentation. It matters for immunity against viruses and tumors, for vaccination and for peripheral tolerance. Two routes are described: the vacuolar pathway, in which antigen is degraded in endosomes or lysosomes (mainly by cathepsin S) and loaded on MHC I there, and the endosome-to-cytosol pathway, in which antigen moves to the cytosol, is degraded by the proteasome and depends on TAP. Most studies report the second route, and the in vivo importance of each is poorly characterized.
Two details are often skipped in general overviews. First, DCs limit rapid lysosomal degradation, which would reduce cross-presentation, by having fewer lysosomal proteases and by alkalizing endosomes through NOX2-generated reactive oxygen species. Second, the receptor that takes up the antigen changes the outcome: uptake through the mannose receptor leads to protected early endosomes and efficient cross-presentation, whereas uptake through DEC205 leads to lysosomal degradation and poor cross-presentation.
Priming CD8 T cells
Both direct presentation and cross-presentation can contribute to priming CD8 T cells. Help from CD4 T cells and type I interferons is involved, mediated through CD40 on DCs and CD40 ligand on CD4 T cells.
Dendritic cell subsets and their functions
| Subset | Markers and dependencies reported | Main function described |
|---|---|---|
| cDC1 | XCR1 (mouse and human); development depends on IRF8 and Batf3; mouse CD8 (lymphoid tissue) or CD103 (non-lymphoid); human BDCA-3 (CD141) | Generally considered the potent cross-presenting DCs in vivo; specialized for CD8 T cell priming through cross-presentation |
| cDC2 | Development depends mainly on IRF4; lineage is heterogeneous; CD11b+ | Captures antigen at infection sites; can also cross-present; role in T cell priming largely non-redundant with cDC1 |
| pDC | Reported as a distinct lineage alongside the cDCs | Potent producers of type I interferons in response to viral pathogens; human pDCs can cross-present, but their in vivo role is described as questionable |
| moDC | Inflammatory monocyte-derived; modeled in vitro with GM-CSF and IL-4 | Common human in vitro model of DC function |
The exact in vivo contribution of each subset to cross-presentation is still debated.
Where it matters for labs, clinics and supply decisions
DC function readouts depend on the model. The sources listed below make several points that change how an assay result should be read:
- No common protocol. The authors of a 2018 cross-presentation review call for common protocols, especially for bone marrow-derived DC (BM-DC) culture, because contradictory results are widespread.
- Time since stimulation. The T cell-priming capacity of BM-DCs declines after 24 hours following TLR stimulation, linked to lower costimulatory molecules. The timing of the readout is therefore part of the result.
- Culture conditions are not physiology. Many in vitro culture conditions use nutrient levels higher than in vivo, so results may not fully reflect physiology. moDCs, a common human model, are generated with GM-CSF and IL-4.
- Environment shapes function. High lactate in the local environment of differentiating or maturing DCs induces tolerance, and in tumors DCs shift from pro-inflammatory to tolerogenic.
- Subset identity matters. A result from one subset (for example cDC1 cross-presentation) should not be generalized to all DCs. Subsets are distinguished by markers such as XCR1 and CD141; for how marker panels are read, see What Is a Flow Cytometer?.
A practical checklist when reading or planning a DC assay: which subset or model was used, how it was generated, how long after stimulation it was read, which uptake receptor delivered the antigen, and whether the culture medium reflects in vivo nutrient levels.
Common misunderstandings
All dendritic cells are equivalent
They are not. DCs comprise several lineages, and cDC1 and cDC2 have largely non-redundant functions in priming and regulating T cell responses.
Plasmacytoid DCs are the main cross-presenters
cDC1s are generally considered the potent cross-presenting DCs in vivo. Human pDCs can cross-present, but their role in vivo is described as questionable; in one study, depleting them did not affect viral antigen clearance.
Cross-presentation has one pathway
Two routes are described (vacuolar and endosome-to-cytosol), and which matters most in vivo is not settled.
Cultured DCs behave like DCs in the body
Culture models are useful but have known differences from in vivo conditions, as listed above.
FAQ
What are the functions of dendritic cells?
They capture antigen, mature after TLR signals, migrate toward lymphatic vessels and present antigen to T cells, including cross-presentation on MHC class I to prime CD8 T cells. Some subsets also produce type I interferons (pDCs).
What is the function of dendritic cells in tolerance?
Cross-presentation matters for peripheral tolerance as well as for immunity. Conditions such as high lactate can push maturing DCs toward a tolerogenic state.
Which dendritic cells are best at cross-presentation?
cDC1s are generally considered the potent cross-presenting DCs in vivo, though cDC2s and even human pDCs can also cross-present.
Sources
- Embgenbroich M, Burgdorf S. Current Concepts of Antigen Cross-Presentation. Front Immunol 2018;9:1643. Frontiers in Immunology (checked 2026-10-29).
- Theisen D, Murphy K. The role of cDC1s in vivo: CD8 T cell priming through cross-presentation. F1000Research 2017;6:98. PubMed Central (checked 2026-10-29).
- Brombacher EC, Everts B. Shaping of Dendritic Cell Function by the Metabolic Micro-Environment. Front Endocrinol 2020;11:555. PubMed Central (checked 2026-10-29).
